Sagility Limited announced the appointment of Mr. Srinivas Rathnam Mattapalli as the new Group Chief Financial Officer, effective February 14, 2026. He is designated as a Key Managerial Personnel (KMP). Mr. Mattapalli is an industry veteran with over 30 years of experience, bringing expertise in P&L management and digital transformation from global firms like Genpact and Hindustan Coca-Cola.
Key Managerial Personnel Change Approved
The Board of Directors of Sagility Limited, following recommendations from the Nomination & Remuneration Committee and the Audit Committee, has approved a significant change in its senior management team. The meeting was brief, commencing at 7:50 p.m. (IST) and concluding at 7:55 p.m. (IST) on February 14, 2026.
Appointment of Group CFO
Mr. Srinivas Rathnam Mattapalli has been appointed to the role of Group Chief Financial Officer. Concurrently, he has been designated as a Key Managerial Personnel (KMP) for the company. The effective date for this leadership transition is February 14, 2026.
Professional Background of Mr. Mattapalli
Mr. Mattapalli is recognized as an industry veteran in Finance, bringing over 30 years of experience driving business transformation across global organizations. His core expertise lies in P&L management, pricing strategy, and digital transformation initiatives. Most recently, he served as a Senior Vice President at Genpact (NYSE: G), where he held several leadership roles, including Business CFO for the Hi-Tech and Manufacturing vertical.
Prior to Genpact, his career included significant tenures at eFunds (FIS), Hindustan Coca-Cola, and Colgate-Palmolive, handling responsibilities spanning SBU finance leadership and ERP implementations.
Educational Credentials
Academically, Mr. Mattapalli holds a Bachelor’s degree in Commerce from Osmania University and is a qualified ICWA professional. Furthermore, he is an alumnus of IIM Bangalore, where he completed a Post Graduate Diploma in Management, specializing in Finance and International Business.
Compliance Statement
The company confirms that all relevant details required under the applicable regulations are enclosed and that this disclosure fulfills the obligations under Regulation 30. This information is also being hosted on the Company’s official website, https://sagilityhealth.com/, for public record.
Source: BSE
